SENTINEL LYMPH NODE BIOPSY AFTER NEOADJUVANT CHEMOTHERAPY IN CLINICALLY NODE POSITIVE AXILLA OF BREAST CANCER

Evaluation of Sentinel Lymph Node Biopsy after Neoadjuvant Therapy for Breast Cancer Patients with Positive Axillary Nodes: A Multicenter Study

Evaluation of Sentinel Lymph Node Biopsy After Primary Chemotherapy as Part of De-Escalation of Breast Cancer Treatment

Evaluation of targeted axillary dissection in node positive locally advanced breast cancer patients with complete pathological response to neoadjuvant chemotherapy

Predictive value of axillary nodal mapping after neoadjuvant chemotherapy in breast cancer

Evaluation of sentinel lymph node biopsy using 1% methylene blue in node-responsive postneoadjuvant chemotherapy in patients with breast cancer

Retrospective study to assess axillary management and oncological outcome after neoadjuvant chemotherapy for patients with breast cancer

EVALUATION OF THE AXILLARY NODAL STATUS POST NEO-ADJUVANT CHEMOTHERAPY IN LOCALLY ADVANCED FEMALE BREAST CANCER PATIENTS

SENTINEL LYMPH NODES DISSECTION VERSUS AXILLARY LYMPH NODES DISSECTION IN PATIENTS WITH EARLY BREAST CANCER AND SENTINEL NODES METASTASES

Can Sentinel Node Biopsy Continue to Be a Diagnostic Tool for Radiologically Negative Axilla in Early Breast Cancer?